Lung Preservation Systems Market: By Technique, Static Cold Storage, Others), By Solution Solution, Human Biosystem Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User, and Geography
Lung Preservation Systems Market size was valued at US$ 182.6 million in 2023 and is poised to grow at a CAGR of 6.8% from 2024 to 2030. Lung preservation is the process of protecting and maintaining the donor lung from lung procurement up to the implantation in the desired recipients. Perfusion volume and pressure, temperature, oxygenation, and degree of inflation are the key factors impact the lung injury during the preservation or at the time of preservation, and lung function after the transplantation to recipients. Lung procurement is usually performed after the brain death or cardiac death of the patients.
Study Period
2024-2030Base Year
2023CAGR
6.8%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the number of brain death cases due to rise in number of accidents and traumatic injuries is a key factor drives the global market. Moreover, increase in the awareness about the organ donation among the people, government initiations for the organ transplantation procedures, sophisticated healthcare infrastructure in the developed countries, rise in R&D expenditure for the development of newer methods for lungs storage, and favorable reimbursement policies are anticipated to spur the global market over the forecast period.
However, high cost of procedure, dearth of skilled persons in underdeveloped regions, and limited scope at the end user level are hinder the growth of global lung preservation systems market.
North America market is poised to grow due to rise in lung transplantation procedures in U.S. and Canada, rise in consumption of tobacco and alcohol results to lung failure, and well developed healthcare infrastructure are propel the market.
Europe market has prominent share attributed to increase in the recipients for lung transplantation for instance, according to European Commission 2014, approximately 2,100 lung recipients are in the waiting list, rise in healthcare expenditure, and presence of skilled professionals are boost the market.
Asia Pacific market is driving by rise in medical tourism in Asia Pacific countries for organ transplantation, rise in awareness about the organ donation among the people, and entry of market players into Asia Pacific region are bolster the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 182.6 million |
|
Market CAGR |
6.8% |
|
By Technique |
|
|
By Solution |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global lung preservation systems market size was valued at US$ 182.6 million in 2023 and is projected to grow at a CAGR of 6.8% from 2024-2030.
The lung preservation systems market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The lung preservation systems market key players are Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Waters Medical Systems LLC (U.S.), Essential Pharmaceuticals LLC (U.S.), Xvivo Perfusion AB (Sweden), BioLife Solutions, Inc. (U.S.), Preservation Solutions, Inc. (U.S.), Transmedics, Inc. (U.S.), CryoLife, Inc. (U.S.)
| 1.Executive Summary |
| 2.Global Lung Preservation Systems Market Introduction |
| 2.1.Global Lung Preservation Systems Market - Taxonomy |
| 2.2.Global Lung Preservation Systems Market - Definitions |
| 2.2.1.Technique |
| 2.2.2.Solution |
| 2.2.3. End User |
| 2.2.4.Region |
| 3.Global Lung Preservation Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Lung Preservation Systems Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Lung Preservation Systems Market By Technique, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Hypothermic Perfusion Preservation (HPP) |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Static Cold Storage (SCS) |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Lung Preservation Systems Market By Solution, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Human Biosystem (HBS) Solution |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Renograf |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Viaspen |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Lifor |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Perfadex |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Lung Preservation Systems Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Lung Preservation Systems Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Lung Preservation Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Technique Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hypothermic Perfusion Preservation (HPP) |
| 9.1.2.Static Cold Storage (SCS) |
| 9.1.3.Others |
| 9.2. Solution Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 9.2.2.Human Biosystem (HBS) Solution |
| 9.2.3.Renograf |
| 9.2.4.Viaspen |
| 9.2.5.Lifor |
| 9.2.6.Perfadex |
| 9.2.7.Others |
| 9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinics |
| 9.3.3.Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Lung Preservation Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hypothermic Perfusion Preservation (HPP) |
| 10.1.2.Static Cold Storage (SCS) |
| 10.1.3.Others |
| 10.2. Solution Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 10.2.2.Human Biosystem (HBS) Solution |
| 10.2.3.Renograf |
| 10.2.4.Viaspen |
| 10.2.5.Lifor |
| 10.2.6.Perfadex |
| 10.2.7.Others |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Others |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Lung Preservation Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hypothermic Perfusion Preservation (HPP) |
| 11.1.2.Static Cold Storage (SCS) |
| 11.1.3.Others |
| 11.2. Solution Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 11.2.2.Human Biosystem (HBS) Solution |
| 11.2.3.Renograf |
| 11.2.4.Viaspen |
| 11.2.5.Lifor |
| 11.2.6.Perfadex |
| 11.2.7.Others |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Others |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Lung Preservation Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hypothermic Perfusion Preservation (HPP) |
| 12.1.2.Static Cold Storage (SCS) |
| 12.1.3.Others |
| 12.2. Solution Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 12.2.2.Human Biosystem (HBS) Solution |
| 12.2.3.Renograf |
| 12.2.4.Viaspen |
| 12.2.5.Lifor |
| 12.2.6.Perfadex |
| 12.2.7.Others |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Others |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Lung Preservation Systems Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hypothermic Perfusion Preservation (HPP) |
| 13.1.2.Static Cold Storage (SCS) |
| 13.1.3.Others |
| 13.2. Solution Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution |
| 13.2.2.Human Biosystem (HBS) Solution |
| 13.2.3.Renograf |
| 13.2.4.Viaspen |
| 13.2.5.Lifor |
| 13.2.6.Perfadex |
| 13.2.7.Others |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Others |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Franz Kohler Chemie GmbH (Germany) |
| 14.2.2.Organ Recovery Systems (U.S.) |
| 14.2.3.Waters Medical Systems LLC (U.S.) |
| 14.2.4.Essential Pharmaceuticals LLC (U.S.) |
| 14.2.5.Xvivo Perfusion AB (Sweden) |
| 14.2.6.BioLife Solutions, Inc. (U.S.) |
| 14.2.7.Preservation Solutions, Inc. (U.S.) |
| 14.2.8.Transmedics, Inc. (U.S.) |
| 14.2.9.CryoLife, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
